"Specjalistyczna Przychodnia Alergologiczna Centrum Alergologii to prestiżowa placówka medyczna w Lublinie oferująca wysokospecjalistyczne i nowoczesne metody diagnostyki i leczenia chorób alergicznych (w tym swoista immunoterapia alergenowa) dzieci i dorosłych."

During the past decade, NZOZ Centrum Alergologii conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Centrum Alergologii" #1 sponsor was "HAL Allergy" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Optinose US Inc." with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Centrum Alergologii" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Centrum Alergologii" are "Chronic Rhinosinusitis" (4 trials), "Allergic Rhinitis" (2 trials), "Allergic Rhinoconjunctivitis" (2 trials), "Nasal Polyps" (2 trials) and "Allergic Rhinitis Due to Cat Allergy" (1 trials). Many other conditions were trialed in "NZOZ Centrum Alergologii" in a lesser frequency.

Most popular intervention types in "NZOZ Centrum Alergologii" are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "OPN-375" (2 trials), "Omalizumab" (2 trials), "SUBLIVAC FIX Birch" (2 trials) and "BAY1817080" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Centrum Alergologii" are 13 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Centrum Alergologii". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in NZOZ Centrum Alergologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Centrum Alergologii, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".